Virus-Like Particle Derived Vaccines: Safe, Dependable, and Still Exciting

Written by: Beth Rousseau

Editors: Madeline Barron, Will Dana, and Austin Shannon

New and flashy vaccines tend to get all the press, whereas less attention is paid to safe, effective, and well-established vaccine technology, such as vaccines derived from virus-like particles (VLPs). VLP-based vaccines have been on the commercial market for years and include those used to prevent diseases like hepatitis B and cervical cancer. The success of these vaccines is rooted in the science underlying their development and activity in the body. With many new VLP vaccines currently in clinical trials around the world, it is evident that, even amidst the wave of new vaccine technologies, VLPs are here to stay.

Continue reading “Virus-Like Particle Derived Vaccines: Safe, Dependable, and Still Exciting”